最近の論文

印刷

  • HOME
  • 最近の論文
  • 2022年

最近の論文

2024年 | 2023年 | 2022年 | 2021年 | 2020年 | 2019年 | 2018年 | 2017年 | 2016年 | 2015年 | 2014年 | 2013年

2022年

2022年12月5日
Nakadai, T., Yang, L., Kumegawa, K. and Maruyama, R.
Estrogen receptor α K303R mutation reorganizes its binding to forkhead box protein A1 regions and induces chromatin opening.
Molecular biology reports, in press (2022)
2022年11月8日
Haga, Y., Yamada, M., Fujii, R., Saichi, N., Yokokawa, T., Hama, T., Hayakawa, Y. and Ueda, K.
Fast and ultrasensitive glycoform analysis by supercritical fluid chromatography-tandem mass spectrometry.
Anal. Chem., in press (2022)
2022年10月28日
Huang, S., Haga, Y., Li, J., Zhang, J., Kweon, H. K., Seino, J., Hirayama, H., Fujita, M., Moremaen, K., Andrews, P., Suzuki, T. and Wang, Y.
Mitotic phosphorylation inhibits the Golgi mannosidase MAN1A1.
Cell Rep., in press (2022)
2022年8月23日
Minegishi, Y., Kiyotani, K., Nemoto, K., Inoue, Y., Haga, Y., Fujii, R., Saichi, N., Nagayama, S. and Ueda, K.
Differential ion mobility mass spectrometry in immunopeptidomics identifies neoantigens carrying colorectal cancer driver mutations.
Commun. Biol., in press (2022)
2022年8月23日
Ochiai, R., Hayashi, K., Yamamoto, H., Fujii, R., Saichi, N., Shinchi, H., Ishida, T., Honda, T., Shimizu, T., Matsutani, N., Seki, N., Kawamura, M. and Ueda, K.
Plasma exosomal DOK3 reflects immunological states in lung tumor and predicts prognosis of gefitinib treatment.
Cancer Sci., in press (2022)
2022年8月16日
Namikawa, K., Tanaka, N., Ota, Y., Takamatsu, M., Kosugi, M., Tokai, Y., Yoshimizu, S., Horiuchi, Y., Ishiyama, A., Yoshio, T., Hirasawa, T., Amino, S., Furuya, R., Gotoh, O., Kaneyasu, T., Nakayama, I., Imamura, Y., Noda, T., Fujisaki, J. and Mori, S.
Genomic features of Helicobacter pylori-naïve diffuse-type gastric cancer.
J. Pathol., in press (2022)
2022年8月16日
Sakashita, T., Yanagitani, N., Koike, S., Low, S. K., Takagi, S., Baba, S., Takeuchi, K., Nishio, M., Fujita, N. and Katayama, R.
Fibroblast growth factor receptor 3 overexpression mediates ALK inhibitor resistance in ALK-rearranged non-small cell lung cancer.
Cancer Sci., in press (2022)
2022年7月21日
Fukuoka, M., Ichikawa, Y., Osako, T., Fujita, T., Baba, S., Takeuchi, K., Tsunoda, N., Ebata, T., Ueno, T., Ohno, S. and Saitoh, N.
The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer.
Cancer Sci., in press (2022)
2022年7月19日
Igarashi, N., Miyata, K., Loo, T. M., Chiba, M., Hanyu, A., Nishio, M., Kawasaki, H., Zheng, H., Toyokuni, S., Kon, S., Moriyama, K., Fujita, Y. and Takahashi, A.
Hepatocyte growth factor derived from senescent cells attenuates cell competition-induced apical elimination of oncogenic cells.
Nat. Commun., in press (2022)
2022年7月8日
Kunimasa, K., Ikeda-Ishsikawa, C., Tani, Y., Tsukahara, S., Sakurai, J., Okamoto, Y., Koido, M., Dan, S. and Tomida, A.
Spautin-1 inhibits mitochondrial complex I and leads to suppression of the unfolded protein response and cell survival during glucose starvation.
Sci. Rep., 12, 11533 (2022)
2022年6月21日
Shimizu, Y., Maruyama, K., Suzuki, M., Kawachi, H., Low, S. K., Oh-Hara, T., Takeuch, K., Fujita, N., Nagayama, S. and Katayama, R.
Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma.
Cancer Lett., in press (2022)
2022年6月20日
Ebata, H., Loo, T. M. and Takahashi, A.
Telomere maintenance and the cGAS-STING pathway in cancer.
Cells, in press (2022)
2022年6月20日
Kumegawa, K., Takahashi, Y., Saeki, S., Yang, L., Nakadai, T., Osako, T., Mori, S., Noda, T., Ohno, S., Ueno, T. and Maruyama, R.
GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer.
NPJ Breast Cancer, 8, 70 (2022)
2022年5月26日
Ohta, K., Fushimi, T., Okamura, M., Akatsuka, A., Dan, S., Iwasaki, H., Yamashita, M. and Kojima, N.
Structure–antitumor activity relationship of hybrid acetogenins focusing on connecting groups between heterocycles and the linker moiety.
RSC Advances, 12, 15728-15739 (2022)
2022年5月11日
Moyret-Lalle, C., Prodhomme, M. K., Burlet, D., Kashiwagi, A., Petrilli, V., Puisieux, A., Seimiya, H. and Tissier, A.
Role of EMT in the DNA damage response, double-strand break repair pathway choice and its implications in cancer treatment.
Cancer Sci., in press (2022)
2022年5月9日
Tanaka, N., Mori, S., Kiyotani, K., Ota, Y., Gotoh, O., Kusumoto, S., Nakano, N., Suehiro, Y., Ito, A., Choi, I., Ohtsuka, E., Hidaka, M., Nosaka, K., Yoshimitsu, M., Imaizumi, Y., Iida, S., Utsunomiya, A., Noda, T., Nishikawa, H., Ueda, R. and Ishida, T.
Genomic determinants impacting the clinical outcome of mogamulizumab treatment for adult T-cell leukemia/lymphoma.
Haematologica, in press (2022)
2022年5月6日
Adachi, J., Kakudo, A., Takada, Y., Isoyama, J., Ikemoto, N., Abe, Y., Narumi, R., Muraoka, S., Gunji, D., Hara, Y., Katayama, R. and Tomonaga, T.
Systematic identification of ALK substrates by integrated phosphoproteome and interactome analysis.
Life Sci. Alliance, 5, e202101202 (2022)
2022年4月8日
Matsumori, H., Watanabe, K., Tachiwana, H., Fujita, T., Ito, Y., Tokunaga, M., Sakata-Sogawa, K., Osakada, H., Haraguchi, T., Awazu, A., Ochiai, H., Sakata, Y., Ochiai, K., Toki, T., Ito, E., Goldberg, I. G., Tokunaga, K., Nakao, M. and Saitoh, N.
Ribosomal protein L5 facilitates rDNA-bundled condensate and nucleolar assembly.
Life science alliance, 5, e202101045 (2022)
2022年4月6日
Takemoto, A., Takagi, S., Ukaji, T., Gyobu, N., Kakino, M., Takami, M., Kobayashi, A., Lebel, M., Kawaguchi, T., Sugawara, M., Tsuji-Takayama, K., Ichihara, K., Funauchi, Y., Ae, K., Matsumoto, S., Sugiura, Y., Takeuchi, K., Noda, T., Katayama, R. and Fujita, N.
Targeting podoplanin for the treatment of osteosarcoma.
Clin. Cancer Res., in press (2022)
2022年3月18日
Shimizu, Y., Okada, K., Adachi, J., Abe, Y., Narumi, R., Uchibori, K., Yanagitani, N., Koike, S., Takagi, S., Nishio, M., Fujita, N. and Katayama, R.
GSK3 inhibition circumvents and overcomes acquired lorlatinib resistance in ALK-rearranged non-small-cell lung cancer.
NPJ Precis. Oncol., in press (2022)
2022年3月8日
Osako, T., Matsuura, M., Yotsumoto, D., Takayama, S., Kaneko, K., Takahashi, M., Shimazu, K., Yoshidome, K., Kuraoka, K., Itakura, M., Tani, M., Ishikawa, T., Ohi, Y., Kinoshita, T., Sato, N., Tsujimoto, M., Nakamura, S., Tsuda, H., Noguchi, S. and Akiyama, F.
A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort study.
Cancer, in press (2022)
2022年3月3日
Tanimura, K., Yamada, T., Okada, K., Nakai, K., Horinaka, M., Katayama, Y., Morimoto, K., Ogura, Y., Takeda, T., Shiotsu, S., Ichikawa, K., Watanabe, S., Morimoto, Y., Iwasaku, M., Kaneko, Y., Uchino, J., Taniguchi, H., Yoneda, K., Matoba, S., Sakai, T., Uehara, H., Yano, S., Kusaba, T., Katayama, R. and Takayama, K.
HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.
NPJ Precis Oncol, 6, 5 (2022)
2022年2月16日
Miyata, K. and Takahashi, A.
Pericentromeric repetitive ncRNA regulates chromatin interaction and inflammatory gene expression.
Nucleus, 13, 74-78 (2022)
2022年2月14日
Yoshida, Y., Yuki, K., Dan, S., Yamazaki, K. and Noda, M.
Suppression of tumor metastasis by a RECK-activating small molecule.
Sci. Rep., 12, 2319 (2022)
2022年2月14日
Haga, Y. and Ueda, K.
Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques.
Glycoconj J, in press (2022)
2022年1月4日
Sagawa, R., Sakata, S., Gong, B., Seto, Y., Takemoto, A., Takagi, S., Ninomiya, H., Yanagitani, N., Nakao, M., Mun, M., Uchibori, K., Nishio, M., Miyazaki, Y., Shiraishi, Y., Ogawa, S., Kataoka, K., Fujita, N., Takeuchi, K. and Katayama, R.
Soluble PD-L1 through alternative polyadenylation works as a decoy in lung cancer immunotherapy.
JCI insight, in press (2021)

このページのTOPへ